We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

34 hedge funds and large institutions have $4.84M invested in ANI Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

741% more call options, than puts

Call options by funds: $496K | Put options by funds: $59K

Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
34
Increased
–
Reduced
–
Closed
–
Calls
$496K
Puts
$59K
Net Calls
+$437K
Net Calls Change
+$437K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HVC
1
Healthcare Value Capital
New Jersey
$2.54M +$2.62M +374,111 New
BIT
2
BlackRock Institutional Trust
California
$1.25M +$1.46M +208,205 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$535K +$623K +89,062 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$82K +$95.4K +13,626 New
Nomura Holdings
5
Nomura Holdings
Japan
$59K +$69.5K +9,928 New
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$51K +$59.8K +8,540 New
Northern Trust
7
Northern Trust
Illinois
$38K +$44.5K +6,352 New
Renaissance Technologies
8
Renaissance Technologies
New York
$36K +$41.7K +5,959 New
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$34K +$39.1K +5,589 New
Goldman Sachs
10
Goldman Sachs
New York
$33K +$38.4K +5,485 New
Bank of America
11
Bank of America
North Carolina
$28K +$32.5K +4,642 New
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$24K +$27.5K +3,927 New
U
13
UBS
Switzerland
$24K +$27.8K +3,971 New
GC
14
Guggenheim Capital
Illinois
$23K +$26.3K +3,761 New
ZIG
15
Zuckerman Investment Group
Illinois
$15K +$17.6K +2,509 New
State Street
16
State Street
Massachusetts
$13K +$15.2K +2,173 New
KCG
17
Knight Capital Group
$13K +$15.6K +2,231 New
Citadel Advisors
18
Citadel Advisors
Florida
$13K +$15.7K +2,244 New
BA
19
BlackRock Advisors
Delaware
$9K +$10.5K +1,497 New
Barclays
20
Barclays
United Kingdom
$5K +$5.67K +811 New
TRCT
21
Tower Research Capital (TRC)
New York
$5K +$6.33K +905 New
RFC
22
Russell Frank Company
Washington
$3K +$2.97K +425 New
Group One Trading
23
Group One Trading
Illinois
$3K +$3.39K +484 New
Citigroup
24
Citigroup
New York
$2K +$1.6K +229 New
ClearBridge Investments
25
ClearBridge Investments
New York
$1K +$175 +25 New
1
2

ANIP Hedge Fund Activity: Q2 2013 in Review

34 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q2 2013, worth a combined $4.84M.

Buyers outnumbered sellers: 34 funds opened new ANIP positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

  • 34 institutional investors held ANI Pharmaceuticals (ANIP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $4.84M of ANI Pharmaceuticals stock for Q2 2013.
  • 34 funds opened new ANI Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +34 holders.

Based on aggregated 13F filings for Q2 2013.